<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02847013</url>
  </required_header>
  <id_info>
    <org_study_id>00005133</org_study_id>
    <nct_id>NCT02847013</nct_id>
  </id_info>
  <brief_title>The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section</brief_title>
  <official_title>The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This present investigation aims to determine whether a transversus abdominous plane(TAP)
      block, utilizing liposomal bupivacaine (Exparel), at the conclusion of a cesarean section
      decreases post-operative pain. The hypothesis is that performance of the TAP block with
      liposomal bupivacaine will decrease post-operative narcotic use.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2018</start_date>
  <completion_date type="Anticipated">August 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative narcotic use</measure>
    <time_frame>initial 48 hours postoperatively</time_frame>
    <description>Patient use of standard postoperative narcotics (percocet) will be measured.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective pain scores using 1-10 VAS system</measure>
    <time_frame>initial 48 hours postoperatively</time_frame>
    <description>Subjective pain scores using 1-10 VAS system will be measured</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Placebo- Tap block w normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After completion of surgery with closer of skin incision a TAP block will be performed. On confirmation of entering the fascial plane, 20cc of Normal saline will be injected after negative aspiration. That will complete the intervention. 20 patients will be in this arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention-Tap block w Liposomal bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After completion of surgery w closure of skin incision a TAP block will be performed. On confirmation of entering the fascial plane, Liposomal bupivacaine 0.33% (10 ml diluted to 20 ml using sterile normal saline) will be injected after negative aspiration. That will complete the intervention. 20 patients will be in this arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TAP block w Liposomal bupivacaine</intervention_name>
    <description>TAP block w Liposomal bupivacaine diluted to 0.66% (20 mLs)</description>
    <arm_group_label>Intervention-Tap block w Liposomal bupivacaine</arm_group_label>
    <other_name>Exparel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TAP block w normal saline</intervention_name>
    <description>TAP block w normal saline -preservative free 0.9% sodium chloride (20mLs)</description>
    <arm_group_label>Placebo- Tap block w normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt;18 years of age

          -  Scheduled cesarean section with or without bilateral tubal ligation

          -  Planned performance of a Pfannenstiel incision

          -  Patients are schedule to have a cesarean section with a member of the Women's Health
             or Maternal and Fetal Medicine Departments at Penn State University Hershey S. Medical
             Center

        Exclusion Criteria:

          -  History of opioid use

          -  History of chronic pain syndrome

          -  Use of general anesthesia during cesarean delivery

          -  Postoperative SICU admission

          -  Postpartum hemorrhage (defined as an Estimated Blood Loss of greater then 1,000mL upon
             completion of the cesarean section)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaimey Pauli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Milton S. Hershey Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephen Wagner, MD</last_name>
    <phone>717-531-0003</phone>
    <phone_ext>287994</phone_ext>
    <email>swagner2@hmc.psu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ian Waldman, MD</last_name>
    <phone>717 531 0003</phone>
    <phone_ext>287994</phone_ext>
    <email>iwaldman@pennstatehealth.psu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033-0850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jaimey Pauli, M.D.</last_name>
      <phone>717-531-8142</phone>
      <phone_ext>5</phone_ext>
      <email>jpauli@pennstatehealth.psu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Stephen Wagner, M.D.</last_name>
      <phone>717-531-0003</phone>
      <phone_ext>287994</phone_ext>
      <email>swagner2@pennstatehealth.psu.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2016</study_first_submitted>
  <study_first_submitted_qc>July 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2016</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Jaimey M. Pauli, MD</investigator_full_name>
    <investigator_title>OB/GYN Resident</investigator_title>
  </responsible_party>
  <keyword>Postcesarean Section</keyword>
  <keyword>Postoperative</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

